Processing

Please wait...

Settings

Settings

Goto Application

1. WO1997049396 - USE OF LOFEXIDINE IN THE MANUFACTURE OF A MEDICAMENT FOR TREATING ATTENTION DEFICIT HYPERACTIVE DISORDER

Publication Number WO/1997/049396
Publication Date 31.12.1997
International Application No. PCT/GB1997/001713
International Filing Date 24.06.1997
IPC
A61K 31/415 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
4151,2-Diazoles
A61K 31/4164 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
41641,3-Diazoles
CPC
A61K 31/415
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
4151,2-Diazoles
A61K 31/4164
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
41641,3-Diazoles
Applicants
  • BRITANNIA PHARMACEUTICALS LIMITED [GB]/[GB]
Inventors
  • ARNSTEN, Amy
  • DAVIES, Keith
Agents
  • WOODCRAFT, David, Charles
Priority Data
9613243.625.06.1996GB
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) USE OF LOFEXIDINE IN THE MANUFACTURE OF A MEDICAMENT FOR TREATING ATTENTION DEFICIT HYPERACTIVE DISORDER
(FR) UTILISATION DE LOFEXIDINE DANS LA FABRICATION D'UN MEDICAMENT PERMETTANT DE TRAITER L'HYPERACTIVITE AVEC DEFICIT DE L'ATTENTION
Abstract
(EN)
The invention relates to the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Lofexidine is used for control of ADHD. Typical doses are from 0.005 to 0.02 mg/kg.
(FR)
Cette invention concerne le traitement de l'hyperactivité avec déficit de l'attention (HDA). On utilise de la lofexidine pour réguler la HDA. Les doses courantes varient entre 0,005 et 0,02 mg/kg.
Also published as
Other related publications
Latest bibliographic data on file with the International Bureau